Scientists used patient derived organoids to study the epithelial-specific transcriptional and secretome signatures of the ileum during Crohn’s disease with varying phenotypes to screen for disease profiles and potential druggable targets.
[Cellular and Molecular Gastroenterology and Hepatology]